Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Büscheck

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Endocrine Pathology|March 8, 2020
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine CarcinomasChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
Genes, Chromosomes & Cancer|January 10, 2019
5q21 deletion is often heterogeneous in prostate cancerMartina Kluth, Zaid Al Kilani, Cansu Özden, et al.
World Journal of Surgical Oncology|June 15, 2020
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinomaTill Eichenauer, Navid Shadanpour, Martina Kluth, et al.
Pathology International|April 22, 2020
Upregulation of PTTG1 is associated with poor prognosis in prostate cancerChristoph Fraune, Serhiy Yehorov, Andreas M Luebke, et al.
Biomedicines|May 25, 2024
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 TumorsFlorian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, et al.
Pathology International|August 11, 2020
High B7-H3 expression is linked to increased risk of prostate cancer progressionSarah Bonk, Pinar Tasdelen, Martina Kluth, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Endocrine Pathology|March 8, 2020
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine CarcinomasChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Cancer Management and Research|December 5, 2018
Deletion of 3p13 is a late event linked to progression of <i>TMPRSS2</i>:<i>ERG</i> fusion prostate cancerMartina Kluth, Heinke Volta, Mohammad Hussein, et al.
Cancer Biology & Medicine|February 25, 2021
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancerAndreas Marx, Lena Koopmann, Doris Höflmayer, et al.
Oncotarget|November 19, 2016
Deletion of 18q is a strong and independent prognostic feature in prostate cancerMartina Kluth, Maximilian Graunke, Christina Möller-Koop, et al.
Genes, Chromosomes & Cancer|January 10, 2019
5q21 deletion is often heterogeneous in prostate cancerMartina Kluth, Zaid Al Kilani, Cansu Özden, et al.
World Journal of Surgical Oncology|June 15, 2020
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinomaTill Eichenauer, Navid Shadanpour, Martina Kluth, et al.
Pathology International|April 22, 2020
Upregulation of PTTG1 is associated with poor prognosis in prostate cancerChristoph Fraune, Serhiy Yehorov, Andreas M Luebke, et al.
Biomedicines|May 25, 2024
Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 TumorsFlorian Viehweger, Jennifer Hoop, Lisa-Marie Tinger, et al.
Pathology International|August 11, 2020
High B7-H3 expression is linked to increased risk of prostate cancer progressionSarah Bonk, Pinar Tasdelen, Martina Kluth, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Pageof 12